Emulate, Inc.

Company

Last mentioned: Mar 8, 2026

Timeline

  1. Current Status

    Regulatory bodies and industry leaders report a significant decline in animal-based IND applications.

  2. Industry Pivot

    Major pharma firms like AstraZeneca and Sanofi increase investment in human-on-a-chip technologies.

  3. FDA Modernization Act 2.0

    President Biden signs legislation ending the animal testing mandate.

  4. FD&C Act Passed

    Federal Food, Drug, and Cosmetic Act mandates animal testing for all new drugs.

Stories mentioning Emulate, Inc. 1

Regulation Bullish

Regulatory Shift: The Decline of Animal Testing in Drug Development

The pharmaceutical industry is undergoing a historic shift as the FDA Modernization Act 2.0 ends the decades-long mandate for animal testing. This transition toward New Approach Methodologies (NAMs) like organ-on-a-chip and AI modeling is redefining the legal and regulatory requirements for drug safety validation.

2 sources